Iain Miller has established Healthcare Strategies Group, a London-based organization that provides strategic advisory services to life sciences tools firms and pharmaceutical companies.
Miller is involved in several international policy initiatives, including The European Personalized Medicine association, where he serves as a board member.
Previously, Miller worked at GE Healthcare as the global head of personalized healthcare strategy and partnerships. While at BioMerieux, Miller was senior director of oncology strategy and theranostics, and led strategy and business development activities within the company's personalized medicine business unit.
Exosome Diagnostics has appointed Joseph Slattery to its board of directors.
Slattery is CFO and executive VP of Baxano Surgical. Prior to Baxano, Slattery was CFO and senior VP of the molecular diagnostics firm Digene.